Concepedia

Jocelyn Zhou

JZ

Statistics

Publications

4

Citations

108

H-Index

4

Active since

2016

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Jocelyn Zhou is an author at Novartis (Switzerland) specializing in pharmacology, pharmacokinetics, and cancer pharmacology.

Publications per year

2016–2017

4

Publications

4

Population pharmacokinetics of sonidegib (LDE225), an oral inhibitor of hedgehog pathway signaling, in healthy subjects and in patients with advanced solid tumors

Varun Goel, Eunju Hurh, Andrew M. Stein et al. · Cancer Chemotherapy and Pharmacology · 2016 · 38 citations

, , +14

A Physiologically-Based Pharmacokinetic Modeling Approach To Predict Drug–Drug Interactions of Sonidegib (LDE225) with Perpetrators of CYP3A in Cancer Patients

Heidi J. Einolf, Jocelyn Zhou, Christina S. Won et al. · Drug Metabolism and Disposition · 2017 · 32 citations

, , +16

Effects of Mild to Severe Hepatic Impairment on the Pharmacokinetics of Sonidegib: A Multicenter, Open-Label, Parallel-Group Study

Yves Horsmans, Jocelyn Zhou, Mateva Liudmila et al. · Clinical Pharmacokinetics · 2017 · 21 citations

, , +14

Effect of esomeprazole, a proton pump inhibitor on the pharmacokinetics of sonidegib in healthy volunteers

Jocelyn Zhou, Michelle Quinlan, Kelli Glenn et al. · British Journal of Clinical Pharmacology · 2016 · 17 citations · Full text

, , +13

1–4 of 4